Collectively, these findings suggest that alterations in GAS8-AS1 function likely occur earlier in cancer onset, probably while the tumor remains well-differentiated rather than in aggressive tumors, as genetic hits to this tumor suppressor may help remove obstacles that advanced-stage tumors consider already surpassed. The gene discussed is DRC4; the disease is cancer.